Earnings Summary

Biolife Solutions, Inc.’s revenue fell -2.53% since last year same period to $39.51Mn in the Q2 2023. On a quarterly growth basis, Biolife Solutions, Inc. has generated 4.79% jump in its revenue since last 3-months.

Biolife Solutions, Inc.’s net profit jumped 85.94% since last year same period to $-10.2Mn in the Q2 2023. On a quarterly growth basis, Biolife Solutions, Inc. has generated 24.62% jump in its net profits since last 3-months.

Biolife Solutions, Inc.’s net profit margin jumped 85.58% since last year same period to -25.82% in the Q2 2023. On a quarterly growth basis, Biolife Solutions, Inc. has generated 28.06% jump in its net profit margins since last 3-months.

Biolife Solutions, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.17 - a 0% jump from last quarter’s estimates.

Biolife Solutions, Inc.’s earning per share (EPS) estimates for the current year stand at -0.17.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Biolife Solutions, Inc.’s return on assets (ROA) stands at -0.07.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Biolife Solutions, Inc.’s return on equity (ROE) stands at -0.22.